Get the Stockscreener App
0.349
2.21%
-0.0089
After Hours:
.34
-0.009
-2.58%
Glucotrack Inc stock is traded at $0.349, with a volume of 297.44K.
It is down -2.21% in the last 24 hours and down -32.29% over the past month.
GlucoTrack Inc is a medical device company. It is focused on defining novel approaches that make diabetes management more accurate and convenient for daily living. The company has developed the GlucoTrack model that measures real-time blood glucose levels. The Company is developing an innovative long-term implantable continuous blood glucose monitoring (CBGM) system, built on proven healthcare technologies. It is designed to meet the critical needs of insulin-dependent individuals or those at risk of hypoglycemia in the U.S.
See More
Previous Close:
$0.3579
Open:
$0.3525
24h Volume:
297.44K
Relative Volume:
0.09
Market Cap:
$3.69M
Revenue:
-
Net Income/Loss:
$-8.74M
P/E Ratio:
-0.1702
EPS:
-2.05
Net Cash Flow:
$-8.25M
1W Performance:
+4.48%
1M Performance:
-32.29%
6M Performance:
-99.40%
1Y Performance:
-98.90%
1-Day Range:
$0.333
$0.3625
1-Week Range:
$0.33
$0.46
52-Week Range:
$0.3126
$99.00
Glucotrack Inc Stock (GCTK) Company Profile
Name
Glucotrack Inc
Sector
Industry
Phone
972 (8) 675-7878
Address
301 RT 17 NORTH, RUTHERFORD
Compare GCTK with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GCTK
Glucotrack Inc
|
0.349 | 3.69M | 0 | -8.74M | -8.25M | -2.05 |
|
ISRG
Intuitive Surgical Inc
|
476.63 | 171.84B | 8.35B | 2.32B | 1.30B | 6.41 |
|
BDX
Becton Dickinson Co
|
222.79 | 64.03B | 20.64B | 1.73B | 2.94B | 6.02 |
|
ALC
Alcon Inc
|
86.79 | 43.91B | 9.91B | 1.02B | 665.00M | 2.05 |
|
RMD
Resmed Inc
|
219.60 | 32.15B | 4.93B | 1.25B | 1.38B | 8.47 |
|
BAX
Baxter International Inc
|
34.53 | 17.46B | 17.28B | 108.00M | 391.00M | 0.20 |
Glucotrack Inc Stock (GCTK) Latest News
GCTK stock plunges to 52-week low, touches $0.32 By Investing.com - Investing.com Canada
GCTK stock plunges to 52-week low, touches $0.32 - Investing.com
Glucotrack Appoints Guillermo Umpierrez, MD, CDCES, FACE, MACP To Medical Advisory Board - citybiz
GlucoTrack Appoints Dr. Umpierrez to Advisory Board - TipRanks
Glucotrack Appoints Guillermo Umpierrez, MD, CDCES, FACE, MACP as New Medical Advisory Board Member - The Manila Times
Should You Forget Nvidia and Buy 2 Artificial Intelligence (AI) Stocks Instead? - The Globe and Mail
Glucotrack Advances Diabetes Monitoring with Innovative Continuous Blood Glucose Monitor - citybuzz -
GCTK stock plunges to 52-week low at $0.39 amid market challenges - Investing.com Nigeria
GCTK stock plunges to 52-week low at $0.39 amid market challenges By Investing.com - Investing.com South Africa
Global Continuous Glucose Monitoring Devices Market Insights 2025: Key Trends, Market Size, and Growth - EIN News
Glucotrack soars on completion of first human clinical study of continuous blood glucose monitor - MSN
Volcon, Inc. and GlucoTrack, Inc. See Massive Gains, While Omega Therapeutics and Universe Pharmaceuticals Struggle - HPBL
Glucotrack reports success in first human glucose monitor trial - MSN
Glucotrack Inc Stock (GCTK) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.47%
0.16%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):